Voltaren Gel Restriction on Back and Hip
Voltaren (diclofenac) gel has not been evaluated for use on the back or hip, and the FDA-approved indication specifically excludes these anatomical sites due to lack of efficacy and safety data for these locations. 1
FDA-Approved Indications
The FDA label explicitly states that Voltaren Gel is indicated only for osteoarthritis of joints amenable to topical treatment, such as the knees and hands. The label specifically notes: "Voltaren® Gel has not been evaluated for use on the spine, hip, or shoulder." 1
This restriction is not arbitrary—it reflects fundamental limitations in the drug's ability to penetrate deeply enough to reach these joints effectively.
Why Back and Hip Are Excluded
Anatomical Penetration Limitations
The hip and spine are deep-seated joints covered by substantial soft tissue, muscle, and fat layers that prevent adequate drug penetration to the target site. While topical diclofenac can penetrate skin and permeate to deeper tissues, the concentration achieved depends heavily on the depth of the target structure 2.
- Superficial joints (knees, hands, ankles, elbows) are close to the skin surface, allowing therapeutic drug concentrations to reach the joint space
- Deep joints (hip, spine, shoulder) are too far from the skin surface for topical formulations to deliver clinically meaningful drug concentrations to the affected area
Clinical Evidence Supports Surface Joints Only
Recent research demonstrates that topical diclofenac is probably less efficacious than oral ibuprofen for low back pain, with patients improving by only 6.4 points on the Roland Morris Disability Questionnaire compared to 10.1 points with oral ibuprofen 3. This 2024 emergency department study provides high-quality evidence that topical NSAIDs fail to deliver adequate analgesia for deeper musculoskeletal structures like the back.
Practical Implications
What This Means for Prescribing
- Use Voltaren Gel only for superficial joints: knees, hands, wrists, elbows, ankles
- Do not prescribe for: back pain, hip osteoarthritis, shoulder pain, or any deep-seated joint
- For back/hip pain: Consider oral NSAIDs (if no contraindications exist) or alternative analgesics
Common Pitfall to Avoid
Patients often assume that because topical NSAIDs work for knee pain, they should work equally well for back or hip pain. This is incorrect. The depth of tissue penetration is the limiting factor, not the severity or type of arthritis.
Safety Considerations Remain Important
Even when used on appropriate anatomical sites, Voltaren Gel carries the same black box warnings as oral NSAIDs regarding cardiovascular thrombotic events, myocardial infarction, stroke, and serious gastrointestinal adverse events 1. The topical formulation reduces but does not eliminate systemic exposure and associated risks 4, 5.
Patients should avoid sun exposure on treated areas, as animal studies showed earlier onset of ultraviolet light-induced skin tumors with topical diclofenac 1.